Limited‐stage diffuse large B‐cell lymphoma: current management and challenges-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Limited‐stage diffuse large B‐cell lymphoma: current management and challenges

Published:2021-02-22 Issue:3 Volume:194 Page:508-517
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Zhang Xiao‐Yin¹^ORCID,Collins Graham P.¹,Cutter David J.²³,Eyre Toby A.¹^ORCID

Affiliation:

1. Department of Clinical Haematology Oxford University Hospitals NHS Foundation Trust OxfordUK

2. Department of Oncology Oxford University Hospitals NHS Foundation Trust OxfordUK

3. Clinical Trial Service Unit Nuffield Department of Population Health University of Oxford Oxford UK

Funder

Cancer Research UK

British Heart Foundation

Medical Research Council

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17359

Reference61 articles.

1. Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy

2. Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736

3. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

4. Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma

5. Positron Emission Tomography–Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long non-coding RNA (LncRNA) CHROMR promotes the expression of the CNNM1 gene by adsorbing hsa-miR-1299 to obtain drug resistance in diffuse large B lymphoma cells;Translational Cancer Research;2022-05

2. Updates in the Management of Early-Stage Diffuse Large B-Cell Lymphoma;Journal of the National Comprehensive Cancer Network;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3